192 related articles for article (PubMed ID: 9071477)
1. Biological and radiological responses to oral etidronate and tiludronate in Paget's disease of bone.
Devogelaer JP; Malghem J; Stasse P; Nagant de Deuxchaisnes C
Bone; 1997 Mar; 20(3):259-61. PubMed ID: 9071477
[TBL] [Abstract][Full Text] [Related]
2. Comparative prospective, double-blind, multicenter study of the efficacy of tiludronate and etidronate in the treatment of Paget's disease of bone.
Roux C; Gennari C; Farrerons J; Devogelaer JP; Mulder H; Kruse HP; Picot C; Titeux L; Reginster JY; Dougados M
Arthritis Rheum; 1995 Jun; 38(6):851-8. PubMed ID: 7779130
[TBL] [Abstract][Full Text] [Related]
3. The methodology of clinical trials of oral tiludronate in Paget's disease of bone.
Roux C
Bone; 1995 Nov; 17(5 Suppl):497S-499S. PubMed ID: 8573426
[TBL] [Abstract][Full Text] [Related]
4. Treatment with tiludronate has a similar effect to risedronate on Paget's disease activity assessed by bone markers and bone scintigraphy.
Peris P; Alvarez L; Vidal S; Martínez MA; Monegal A; Guañabens N
Clin Exp Rheumatol; 2007; 25(2):206-10. PubMed ID: 17543143
[TBL] [Abstract][Full Text] [Related]
5. Comparative study of alendronate versus etidronate for the treatment of Paget's disease of bone.
Siris E; Weinstein RS; Altman R; Conte JM; Favus M; Lombardi A; Lyles K; McIlwain H; Murphy WA; Reda C; Rude R; Seton M; Tiegs R; Thompson D; Tucci JR; Yates AJ; Zimering M
J Clin Endocrinol Metab; 1996 Mar; 81(3):961-7. PubMed ID: 8772558
[TBL] [Abstract][Full Text] [Related]
6. Extensive personal experience: Paget's disease of bone.
Siris ES
J Clin Endocrinol Metab; 1995 Feb; 80(2):335-8. PubMed ID: 7852484
[No Abstract] [Full Text] [Related]
7. A randomized, double-blind comparison of risedronate and etidronate in the treatment of Paget's disease of bone. Paget's Risedronate/Etidronate Study Group.
Miller PD; Brown JP; Siris ES; Hoseyni MS; Axelrod DW; Bekker PJ
Am J Med; 1999 May; 106(5):513-20. PubMed ID: 10335722
[TBL] [Abstract][Full Text] [Related]
8. Two cases of monostotic Paget's disease: effects of bisphosphonate.
Hoshiro M; Harada T; Iwai H; Miyatake T; Nishimura A; Ohno Y; Aoki N
Endocr J; 2003 Aug; 50(4):385-92. PubMed ID: 14599111
[TBL] [Abstract][Full Text] [Related]
9. Clinical and radiographic improvement of bone of the second lumbar vertebra in Paget's disease following therapy with etidronate disodium: a case report.
Nicholas JJ; Helfrich DJ; Cooperstein L; Goodman M
Arthritis Rheum; 1989 Jun; 32(6):776-9. PubMed ID: 2500130
[TBL] [Abstract][Full Text] [Related]
10. A review of Paget's disease of bone with a focus on the efficacy and safety of zoledronic acid 5 mg.
Abelson A
Curr Med Res Opin; 2008 Mar; 24(3):695-705. PubMed ID: 18226324
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the efficacy and safety of oral tiludronate in Paget's disease of bone. A double-blind, multiple-dosage, placebo-controlled study.
Reginster JY; Colson F; Morlock G; Combe B; Ethgen D; Geusens P
Arthritis Rheum; 1992 Aug; 35(8):967-74. PubMed ID: 1642662
[TBL] [Abstract][Full Text] [Related]
12. Management of Paget's disease of bone.
Langston AL; Ralston SH
Rheumatology (Oxford); 2004 Aug; 43(8):955-9. PubMed ID: 15187244
[TBL] [Abstract][Full Text] [Related]
13. Consensus statement on the modern therapy of Paget's disease of bone from a Western Osteoporosis Alliance symposium. Biannual Foothills Meeting on Osteoporosis, Calgary, Alberta, Canada, September 9-10, 2000.
Drake WM; Kendler DL; Brown JP
Clin Ther; 2001 Apr; 23(4):620-6. PubMed ID: 11354395
[TBL] [Abstract][Full Text] [Related]
14. Pamidronate is effective for Paget's disease of bone refractory to conventional therapy.
Wimalawansa SJ; Gunasekera RD
Calcif Tissue Int; 1993 Oct; 53(4):237-41. PubMed ID: 8275351
[TBL] [Abstract][Full Text] [Related]
15. Etidronate disodium in the treatment of Paget's disease of bone.
Krane SM
Ann Intern Med; 1982 May; 96(5):619-25. PubMed ID: 6280538
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of drugs for Paget's disease of bone.
Reginster JY; Lecart MP
Bone; 1995 Nov; 17(5 Suppl):485S-488S. PubMed ID: 8573423
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic strategy in Paget's disease of bone.
Meunier PJ; Vignot E
Bone; 1995 Nov; 17(5 Suppl):489S-491S. PubMed ID: 8573424
[TBL] [Abstract][Full Text] [Related]
18. Intravenous disodium etidronate therapy in Paget's disease of bone and hypercalcemia of malignancy. Effects on biochemical parameters and bone histomorphometry.
Meunier PJ; Chapuy MC; Delmas P; Charhon S; Edouard C; Arlot M
Am J Med; 1987 Feb; 82(2A):71-8. PubMed ID: 3103438
[TBL] [Abstract][Full Text] [Related]
19. Beneficial effects of aminohexane diphosphonate in patients with Paget's disease of bone resistant to sodium etidronate.
Delmas PD; Chapuy MC; Edouard C; Meunier PJ
Am J Med; 1987 Aug; 83(2):276-82. PubMed ID: 3113247
[TBL] [Abstract][Full Text] [Related]
20. Tiludronate therapy for Paget's disease of bone.
McClung MR; Tou CK; Goldstein NH; Picot C
Bone; 1995 Nov; 17(5 Suppl):493S-496S. PubMed ID: 8573425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
